Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2024 Apr 14:2024.04.10.588876.
doi: 10.1101/2024.04.10.588876.

Cross-platform proteomics signatures of extreme old age

Affiliations

Cross-platform proteomics signatures of extreme old age

Eric R Reed et al. bioRxiv. .

Update in

  • Cross-platform proteomics signatures of extreme old age.
    Reed ER, Chandler KB, Lopez P, Costello CE, Andersen SL, Perls TT, Li M, Bae H, Soerensen M, Monti S, Sebastiani P. Reed ER, et al. Geroscience. 2025 Feb;47(1):1199-1220. doi: 10.1007/s11357-024-01286-x. Epub 2024 Jul 25. Geroscience. 2025. PMID: 39048883 Free PMC article.

Abstract

In previous work we used a Somalogic platform targeting approximately 5000 proteins to generate a serum protein signature of centenarians that we validated in independent studies that used the same technology. We set here to validate and possibly expand the results by profiling the serum proteome of a subset of individuals included in the original study using liquid chromatography tandem mass spectrometry (LC-MS/MS). Following pre-processing, the LC-MS/MS data provided quantification of 398 proteins, with only 266 proteins shared by both platforms. At 1% FDR statistical significance threshold, the analysis of LC-MS/MS data detected 44 proteins associated with extreme old age, including 23 of the original analysis. To identify proteins for which associations between expression and extreme-old age were conserved across platforms, we performed inter-study conservation testing of the 266 proteins quantified by both platforms using a method that accounts for the correlation between the results. From these tests, a total of 80 proteins reached 5% FDR statistical significance, and 26 of these proteins had concordant pattern of gene expression in whole blood. This signature of 80 proteins points to blood coagulation, IGF signaling, extracellular matrix (ECM) organization, and complement cascade as important pathways whose protein level changes provide evidence for age-related adjustments that distinguish centenarians from younger individuals.

Keywords: Serum proteomics; extreme longevity; mass spectrometry; somalogic.

PubMed Disclaimer

Conflict of interest statement

Statements and Declarations: Competing interests. The authors declare no competing interests.

Figures

Figure 1:
Figure 1:. Inter-study protein signatures comparing centenarians to offspring and unrelated controls.
A. Euler plot of protein signatures detected in the mass spectrometry data set with 50 subjects (Mass Spec), the SomaScan subsetwith the same 50 subjects (SomaScan Subset), and the SomaScan data with 224 participants (Somascan). Numbers in parentheses with a “*” denote the proteins that were included in both data sets but detected only in one analysis. B. Fisher’s Exact Test results of the intersection between mass spectrometry and SomaScan signatures. The diagonal represents the number of significant proteins from each analysis that are annotated by the SomaScan assay. C. Comparison of log2 fold changes protein expression differences of controls and offspring to centenarians from mass spectrometry and SomaScan studies across their 266 shared proteins. D. Log2 fold changes protein expression differences inter-study conserved proteins, including each mass spectrometry result and SomaScan aptamer. All protein signature results shown were idenRfied using an FDR cutoff of 0.01. The full set of analysis results are reported in Supplementary Table S2.
Figure 2:
Figure 2:. Protein interaction and functional analysis results
These results reflect analyses of 96 protein signature of proteins with conserved (FDR values < 0.05) and mass spectrometry-only discovered proteins (FDR < 0.01). A. Overrepresentation-based enrichment analysis comparing Gene Ontology Functional Terms and Reactome pathways to three protein lists: All 96 proteins (All), 44 proteins with higher expression in offspring and controls (Up in Off./Cont.), and 52 proteins with higher expression in centenarians (Up in Centenarians). Additional information for these results, including term source, p-values, set sizes, and set members are reported in Supplementary Table S3. B. STRING database annotated protein physical and functional interactions. The full list of interaction pairs is reported in Supplementary Table S4.
Figure 3:
Figure 3:. Summary of literature and Reactome database confirmed protein physical interactions
AddiRonal informaRon, including descripRons of interacRon and sources can be found in Supplementary Table S5.
Figure 4:
Figure 4:. Comparison of mass spectrometry proteomic and LLFS transcriptomic results
Comparison of log2 fold changes from proteomic studies and LLFS gene expression models features characterized by either proteomic conservaRon analysis or transcriptomic analyses that are mappable across plaaorms. Proteomic results reflect differences between either offspring (led) or controls (right) to centenarian cohorts. LLFS transcriptomic results reflect age as a conRnuous variable, i.e. 1-year age differences. Proteins/genes annotated to the neutrophil degranulaRon pathway are highlighted in bold. A. Comparison of the mass spectrometry study and LLFS gene expression features. The plots comprise 123 coinciding protein:gene pairs. The full set of results for these features is reported in Supplemental Table S6. B. Comparison of the published SomaScan signature and LLFS gene expression features. The plots comprise 1,142 coinciding protein:gene pairs. The full set of results for these features is reported in Supplemental Table S7.

Similar articles

References

    1. Cui M, Cheng C, Zhang L (2022) High-throughput proteomics: a methodological mini-review. Lab Invest 102:1170–1181. 10.1038/s41374-022-00830-7 - DOI - PMC - PubMed
    1. Cui S, Wang R, Chen L (2014) Micro RNA ‐145: a potent tumour suppressor that regulates multiple cellular pathways. J Cell Mol Med 18:1913–1926. 10.1111/jcmm.12358 - DOI - PMC - PubMed
    1. Sinha A, Mann M (2020) A beginner’s guide to mass spectrometry–based proteomics. The Biochemist 42:64–69. 10.1042/BIO20200057 - DOI
    1. Lollo B, Steele F, Gold L (2014) Beyond antibodies: New affinity reagents to unlock the proteome. PROTEOMICS 14:638–644. 10.1002/pmic.201300187 - DOI - PubMed
    1. Cui M, Cheng C, Zhang L (2022) High-throughput proteomics: a methodological mini-review. Lab Invest 102:1170–1181. 10.1038/s41374-022-00830-7 - DOI - PMC - PubMed

Publication types